Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Lyra Therapeutics Inc (NASDAQ: LYRA) closed the day trading at $18.42 down -24.16% from the previous closing price of $24.28. In other words, the price has decreased by -$24.16 from its previous closing price. On the day, 0.44 million shares were traded. LYRA stock price reached its highest trading level at $23.83 during the session, while it also had its lowest trading level at $18.101.
Ratios:
For a better understanding of LYRA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 7.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 25 ’25 when Waksal Harlan bought 145,370 shares for $0.10 per share.
Palasis Maria bought 39,567 shares of LYRA for $3,545 on Apr 09 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 32179294 and an Enterprise Value of 26027228. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.51 while its Price-to-Book (P/B) ratio in mrq is 6.27. Its current Enterprise Value per Revenue stands at 21.964 whereas that against EBITDA is -0.582.
Stock Price History:
The Beta on a monthly basis for LYRA is 0.09, which has changed by 0.18806458 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, LYRA has reached a high of $37.50, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is 152.54%, while the 200-Day Moving Average is calculated to be 82.41%.
Shares Statistics:
Over the past 3-months, LYRA traded about 611.74K shares per day on average, while over the past 10 days, LYRA traded about 3563215 shares per day. A total of 1.32M shares are outstanding, with a floating share count of 1.12M. Insiders hold about 15.85% of the company’s shares, while institutions hold 36.57% stake in the company. Shares short for LYRA as of 1747267200 were 146567 with a Short Ratio of 0.09, compared to 1744675200 on 44377. Therefore, it implies a Short% of Shares Outstanding of 146567 and a Short% of Float of 13.84.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
